TirzTom said:For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.
I do not accept the framing. The question has been narrowed to the version that has a tidy answer, and the part that was dropped is the part the OP actually asked about.
Worth separating that from tirzepatide, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.
TirzTom said:For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.
Agreeing with TirzTom, and the qualification matters more than the agreement. Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.
Correct me if the detail matters more than I have assumed.
TirzTom said:For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.
Genuinely useful, thank you. I had the facts and not the framework. I will report back once I have actually tried it.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsAdding the clinical framing, because it changes how the question reads. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.
If somebody has the primary source to hand I would rather cite it than paraphrase it.
Reporting back.
Reporting back for the archive rather than for the thread: I did the narrow version of what was suggested, gave it the full interval, and it settled. Posting it because threads without a follow-up are half a thread.